Citation Impact
Citing Papers
DKK1 Antagonizes Wnt Signaling without Promotion of LRP6 Internalization and Degradation
2008
American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis — 2016--Executive Summary
2016
The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates.
1993
Child abuse: Adolescent records vs. adult recall
1990 Standout
P2Y2 receptors are expressed by human osteoclasts of giant cell tumor but do not mediate ATP-induced bone resorption
1998
Osteoporosis
2019 Standout
A review of the biological response to ionic dissolution products from bioactive glasses and glass-ceramics
2011 Standout
Osteoporosis
2006
The effects of Dickkopf-1 antibody on metaphyseal bone and implant fixation under different loading conditions
2011
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Osteoconductivity of strontium‐doped bioactive glass particles: A histomorphometric study in rats
2009
Knocking down dickkopf-1 alleviates estrogen deficiency induction of bone loss. A histomorphological study in ovariectomized rats
2006
Molecular mechanisms of epithelial–mesenchymal transition
2014 Standout
Targeting the Wnt/β-Catenin Pathway to Regulate Bone Formation in the Adult Skeleton
2007
Expression of the Osteoblast Differentiation Factor RUNX2 (Cbfa1/AML3/Pebp2αA) Is Inhibited by Tumor Necrosis Factor-α
2002
Intrinsic Material Properties of Trabecular Bone by Nanoindentation Testing of Biopsies Taken from Healthy Women Before and After Menopause
2012
TGFβ signalling in context
2012 Standout
Dissemination and growth of cancer cells in metastatic sites
2002 Standout
Shared Principles in NF-κB Signaling
2008 Standout
Acidic fermentation in the caecum increases absorption of calcium and magnesium in the large intestine of the rat
1996
The effect of ionic dissolution products of Ca–Sr–Na–Zn–Si bioactive glass on in vitro cytocompatibility
2010
Cross-talk between nuclear receptors and nuclear factor κB
2006
Preventing fractures in elderly people
2003
Secreted and Transmembrane Wnt Inhibitors and Activators
2012
Strontium Ranelate Enhances Callus Strength More Than PTH 1-34 in an Osteoporotic Rat Model of Fracture Healing
2009
Signaling Pathways in Mammary Gland Development
2001
Osteocytes, mechanosensing and Wnt signaling
2008
TiO2 Nanotubes: Synthesis and Applications
2011 Standout
Strontium Ranelate Reduces the Risk of Nonvertebral Fractures in Postmenopausal Women with Osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) Study
2005
Effects of extracellular matrix viscoelasticity on cellular behaviour
2020 StandoutNature
Osteoporosis and Inflammation
2008
A Rate-Limiting Role for Dickkopf-1 in Bone Formation and the Remediation of Bone Loss in Mouse and Primate Models of Postmenopausal Osteoporosis by an Experimental Therapeutic Antibody
2011
The Pathogenesis of Rheumatoid Arthritis
2011 Standout
Bone Quality — The Material and Structural Basis of Bone Strength and Fragility
2006 Standout
Osteoporosis: now and the future
2011 Standout
Strontium ranelate: A physiological approach for optimizing bone formation and resorption
2006
Effects of Raloxifene on Bone Mineral Density, Serum Cholesterol Concentrations, and Uterine Endometrium in Postmenopausal Women
1997 Standout
WNT signaling in bone homeostasis and disease: from human mutations to treatments
2013 Standout
Systematic review of bisphosphonates for hypercalcaemia of malignancy
2004
Regulation of osteoclast activity
1999
Physical fitness in childhood and adolescence: a powerful marker of health
2007 Standout
Integrating Patterning Signals: Wnt/GSK3 Regulates the Duration of the BMP/Smad1 Signal
2007
Wnt/β-Catenin Signaling and Disease
2012 Standout
Bone Remodeling
2006
Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-α
2000
Benefits and drawbacks of zinc in glass ionomer bone cements
2011
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Improvements in hip trabecular, subcortical, and cortical density and mass in postmenopausal women with osteoporosis treated with denosumab
2013
Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats.
1994
Wnt signaling as a therapeutic target for bone diseases
2009
Wnt inhibitory factor 1 is epigenetically silenced in human osteosarcoma, and targeted disruption accelerates osteosarcomagenesis in mice
2009
Cytokines, bone remodeling, and estrogen deficiency: a 1998 update
1998
Endocrine Regulation of Energy Metabolism by the Skeleton
2007 Standout
Suppression of Wnt Signaling by Dkk1 Attenuates PTH-Mediated Stromal Cell Response and New Bone Formation
2010
Sarcopenia
2019 Standout
The evolving role of bisphosphonates
2001
Estrogen decreases TNF gene expression by blocking JNK activity and the resulting production of c-Jun and JunD
1999
Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone
2014 StandoutNature
Influence of remodeling on the mineralization of bone tissue
2009
The Binding Between Sclerostin and LRP5 is Altered by DKK1 and by High-Bone Mass LRP5 Mutations
2008
The role of tumor necrosis factor in the pathophysiology of heart failure
2000
Microenvironmental regulation of metastasis
2008 Standout
The Multifunctional Fish Gill: Dominant Site of Gas Exchange, Osmoregulation, Acid-Base Regulation, and Excretion of Nitrogenous Waste
2004 Standout
The calcium-sensing receptor in bone cells: A potential therapeutic target in osteoporosis
2009
Production and Actions of Estrogens
2002 Standout
The Effects of Strontium Ranelate on the Risk of Vertebral Fracture in Women with Postmenopausal Osteoporosis
2004
Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival
2001 Standout
Increased risk of hip fracture among patients with end-stage renal disease
2000
In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells
2003 Standout
Osteogenesis and Bone-Marrow-Derived Cells
2001
Mechanical Stimulation of Bone in Vivo Reduces Osteocyte Expression of Sost/Sclerostin
2007
The Prepubertal Years
2000
The TNF and TNF Receptor Superfamilies
2001 Standout
Quantitative imaging techniques for the assessment of osteoporosis and sarcopenia
2018
Osteoporosis: burden, health care provision and opportunities in the EU
2011
Strontium Ranelate: Dose-Dependent Effects in Established Postmenopausal Vertebral Osteoporosis—A 2-Year Randomized Placebo Controlled Trial
2002
Estrogen’s bone-protective effects may involve differential IL-1 receptor regulation in human osteoclast-like cells
1999
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Cloning, Characterization, and Tissue Distribution of Prolactin Receptor in the Sea Bream (Sparus aurata)
2001
Prolactin Controls Mammary Gland Development via Direct and Indirect Mechanisms
1999
Dickkopf-1 is a master regulator of joint remodeling
2007
Chronic Kidney Disease
2016 Standout
Negative Regulation of Bone Formation by the Transmembrane Wnt Antagonist Kremen-2
2010
Loss-of-function of ACVR1 in osteoblasts increases bone mass and activates canonical Wnt signaling through suppression of Wnt inhibitors SOST and DKK1
2011
Matrix Elasticity Directs Stem Cell Lineage Specification
2006 Standout
Prevention of falls and consequent injuries in elderly people
2005 Standout
Update on Wnt signaling in bone cell biology and bone disease
2011
Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities
2017 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Genetic regulation of osteoclast development and function
2003
Exercise for preventing and treating osteoporosis in postmenopausal women
2011
New strontium-based bioactive glasses: physicochemical reactivity and delivering capability of biologically active dissolution products
2009
MECHANISMS IN ENDOCRINOLOGY: Genetics of human bone formation
2017
American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis — 2016
2016
Predictors of Treatment with Osteoporosis Medications After Recent Fragility Fractures in a Multinational Cohort of Postmenopausal Women
2012
How does Exercise Affect Bone Development during Growth?
2006
The role of Dickkopf-1 in bone development, homeostasis, and disease
2008
Short-Chain Fatty Acids and Human Colonic Function: Roles of Resistant Starch and Nonstarch Polysaccharides
2001 Standout
Molecular Physiology of P2X Receptors
2002 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Materials characterisation and cytotoxic assessment of strontium-substituted bioactive glasses for bone regeneration
2010
Strontium-Delivering Glasses with Enhanced Bioactivity: A New Biomaterial for Antiosteoporotic Applications?
2008
Bone Resorption by Osteoclasts
2000 StandoutScience
Calcium sensing receptor‐dependent and receptor‐independent activation of osteoblast replication and survival by strontium ranelate
2009
Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore
2010 Standout
Conditional Inactivation of Noggin in the Postnatal Skeleton Causes Osteopenia
2012
Osteoblast-Targeted Expression of Sfrp4 in Mice Results in Low Bone Mass
2007
Effects of Lactitol-Oligosaccharides on Calcium and Magnesium Absorption in Rats.
1997
Inhibiting Dickkopf-1 (Dkk1) Removes Suppression of Bone Formation and Prevents the Development of Osteolytic Bone Disease in Multiple Myeloma
2009
Strontium containing bioactive glasses: Glass structure and physical properties
2010
Cellular and molecular mechanisms of osteoporosis
1998
Essential Role of Wnt3a-Mediated Activation of Mitogen-Activated Protein Kinase p38 for the Stimulation of Alkaline Phosphatase Activity and Matrix Mineralization in C3H10T1/2 Mesenchymal Cells
2007
Inhibiting Dickkopf-1 (Dkk1) Removes Suppression of Bone Formation and Prevents the Development of Osteolytic Bone Disease in Multiple Myeloma
2008
Main-chain poly(phosphoester)s: History, syntheses, degradation, bio-and flame-retardant applications
2017
Polymers for 3D Printing and Customized Additive Manufacturing
2017 Standout
Gene-Targeted Mice Lacking the Trex1 (DNase III) 3′→5′ DNA Exonuclease Develop Inflammatory Myocarditis
2004 StandoutNobel
Osteopontin-deficient mice are resistant to ovariectomy-induced bone resorption
1999
Targeted Disruption of the Wnt Regulator Kremen Induces Limb Defects and High Bone Density
2008
Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis*
2000 Standout
Molecular Firefighting—How Modern Phosphorus Chemistry Can Help Solve the Challenge of Flame Retardancy
2018 Standout
Bioactive SrTiO3 Nanotube Arrays: Strontium Delivery Platform on Ti-Based Osteoporotic Bone Implants
2009
Update in New Anabolic Therapies for Osteoporosis
2010
Prolactin: Structure, Function, and Regulation of Secretion
2000 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Geometric cues for directing the differentiation of mesenchymal stem cells
2010 Standout
The Chloride Channel Inhibitor NS3736 Prevents Bone Resorption in Ovariectomized Rats Without Changing Bone Formation
2004
Effects of Strontium on Bone Strength, Density, Volume, and Microarchitecture in Laying Hens
2006
Increased Sclerostin Serum Levels Associated with Bone Formation and Resorption Markers in Patients with Immobilization-Induced Bone Loss
2010
Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy period.
1995
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Differential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 Sites
1997 StandoutScience
Catalytic Asymmetric Protonation of Silyl Ketene Imines
2013 StandoutNobel
Brittle IV Mouse Model for Osteogenesis Imperfecta IV Demonstrates Postpubertal Adaptations to Improve Whole Bone Strength
2004
The Effects of Androgen Deficiency on Murine Bone Remodeling and Bone Mineral Density Are Mediated via Cells of the Osteoblastic Lineage*
1997
Bisphosphonates: Mechanisms of Action
1998
A systematic review of the role of bisphosphonates in metastatic disease
2004
Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis
1995 Standout
Works of Patrick Ammann being referenced
Selective Modification of Bone Quality by PTH, Pamidronate, or Raloxifene
2008
Influence of the Disaccharide Lactitol on Intestinal Absorption and Body Retention of Calcium in Rats
1988
Strontium ranelate: A physiological approach for an improved bone quality
2006
Bone strength and its determinants
2003
Gain in bone mineral mass in prepubertal girls 3–5 years after discontinuation of calcium supplementation: a follow-up study
2001
Comparison of a rapid (2-h) versus a slow (24-h) infusion of alendronate in the treatment of hypercalcemia of malignancy
1992
Intrinsic bone tissue properties in adult rat vertebrae: modulation by dietary protein
2004
Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency.
1997
Mechanisms of Action and Therapeutic Potential of Strontium in Bone
2001
Strontium ranelate improves bone strength in ovariectomized rat by positively influencing bone resistance determinants
2008
Bone density and shape as determinants of bone strength in IGF-I and/or pamidronate-treated ovariectomized rats
1996
Assessing Fracture Risk and Effects of Osteoporosis Drugs: Bone Mineral Density and Beyond
2009
Incorporation and distribution of strontium in bone
2001
Recovery of proximal tibia bone mineral density and strength, but not cancellous bone architecture, after long-term bisphosphonate or selective estrogen receptor modulator therapy in aged rats
2002
Protein intake and bone disorders in the elderly
2001
Strontium ranelate improves implant osseointegration
2010
Strontium ranelate: A novel mode of action leading to renewed bone quality
2004
Dietary Protein Restriction Lowers Plasma Insulin-Like Growth Factor I (IGF-I), Impairs Cortical Bone Formation, and Induces Osteoblastic Resistance to IGF-I in Adult Female Rats1
2000
Protein intake, IGF-1 and osteoporosis
1997
Osteoblasts Are a New Target for Prolactin: Analysis of Bone Formation in Prolactin Receptor Knockout Mice**This work was supported in part by grants from Hoechst Marion Roussel, Inc.
1999
Calcium absorption in rat large intestine in vivo: availability of dietary calcium
1986
Aluminum potentiates the effect of fluoride on tyrosine phosphorylation and osteoblast replication in vitro and bone mass in vivo
1996
Effects of the bisphosphonate tiludronate on bone resorption, calcium balance, and bone mineral density
1993
Prevention of Trabecular Bone Loss Induced by Estrogen Deficiency by a Selective p38α Inhibitor
2008
Strontium Ranelate Treatment Improves Trabecular and Cortical Intrinsic Bone Tissue Quality, a Determinant of Bone Strength
2007
The increase in vertebral bone mass induced in intact rats by long-term administration of the strontium salt S-12911 is directly correlated with vertebral bone strength
1996
Deletion of a Single Allele of the Dkk1 Gene Leads to an Increase in Bone Formation and Bone Mass
2006
Strontium Ranelate Improves Bone Resistance by Increasing Bone Mass and Improving Architecture in Intact Female Rats
2004
Sequential and precise in vivo measurement of bone mineral density in rats using dual-energy x-ray absorptiometry
1992